Clinical Trial

Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate the expression level of SLC25A48, a mitochondrial choline transporter, in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease, and to analyze its correlation with inflammatory markers and choline metabolic byproducts.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-07
Trial Details
NCT Number NCT07474220
Lead Sponsor Fu Jen Catholic University
Conditions Chronic Obstructive Pulmonary Disease
Enrollment 180 participants
Start Date 2026-06-29
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-06